Enhancement of the antitumor activity of adriamycin by Tween 80
- PMID: 675847
- DOI: 10.1177/030089167806400202
Enhancement of the antitumor activity of adriamycin by Tween 80
Abstract
This paper describes the effect of Tween 80 on the antitumor activity and on the distribution of adriamycin in mice. The dilution of adriamycin in a 10% water solution of Tween 80 produced a significant increase of the antitumor activity in mice against ascites tumors (L 1210 leukemia), disseminated leukemias (transplanted leukemias originally induced by Gross leukemai virus and Moloney leukemia virus), and solid tumors (Sarcoma 180, MS-2 sarcoma). In all these experiments the drug was administered i.v., according to different schedules. Higher antitumor activity at the optimal dose and an increase of activity at lower doses were observed in different experimental systems. Toxicity was also slightly enhanced. Tissue distribution was studied in normal mice and in tumor-bearing mice (Gross leukemia and MS-2 sarcoma). In animals give i.v. adriamycin diluted in 10% Tween 80 there was a higher drug concentration in spleen, lung and kidney than there was in mice given the drug in a water solution. In all the other organs examined (heart, liver, small intestine) and in the MS-2 tumor tissue, no significant increase was observed. In L1210 leukemia-bearing mice, i.p. treatment with adriamycin diluted in 10% Tween 80 resulted in a significantly higher toxicity than that which resulted from treatment with adriamycin in a wa ter solution; no increase of antitumor activity was observed.
Similar articles
-
Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.Cancer Treat Rep. 1978 Jan;62(1):105-10. Cancer Treat Rep. 1978. PMID: 626988
-
Effect of Tween 80 on adriamycin cytotoxicity in murine P388 leukemia.Tumori. 1984 Aug 31;70(4):313-5. doi: 10.1177/030089168407000403. Tumori. 1984. PMID: 6474580
-
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.Gan. 1977 Oct;68(5):685-90. Gan. 1977. PMID: 579346
-
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.Invest New Drugs. 1985;3(1):3-21. doi: 10.1007/BF00176819. Invest New Drugs. 1985. PMID: 3886588 Review.
-
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.Cancer Treat Rev. 1983 Mar;10(1):1-22. doi: 10.1016/s0305-7372(83)80029-2. Cancer Treat Rev. 1983. PMID: 6342772 Review.
Cited by
-
Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.Clin Pharmacokinet. 2003;42(7):665-85. doi: 10.2165/00003088-200342070-00005. Clin Pharmacokinet. 2003. PMID: 12844327 Review.
-
Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.Urol Res. 1983;11(1):39-42. doi: 10.1007/BF00272708. Urol Res. 1983. PMID: 6407169
-
Initial and early effects of adriamycin in murine sarcoma 180 cannot be restored in a resistant subline by increasing the uptake and external concentration of the drug.Cancer Chemother Pharmacol. 1989;24(1):33-40. doi: 10.1007/BF00254102. Cancer Chemother Pharmacol. 1989. PMID: 2720889
-
Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.Urol Res. 1987;15(1):17-20. doi: 10.1007/BF00256329. Urol Res. 1987. PMID: 3103302
-
Cell biological mechanisms of multidrug resistance in tumors.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3497-504. doi: 10.1073/pnas.91.9.3497. Proc Natl Acad Sci U S A. 1994. PMID: 7909602 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources